Search

everythinglearnresearchcommunity

for

Search:↓

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Finasteride effectively reduces prostate size and symptoms in most BPH patients.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

Early hormones shape sex-specific differences in rat glands.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Many drugs, not just chemotherapy, can cause reversible hair loss.

Roota Hair Growth promotes fuller, healthier hair using plant-based ingredients and requires consistent use.

Roota Hair Growth promotes fuller, healthier hair using plant-based ingredients.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Combining α-blockers and Finasteride is useful for treating small prostate enlargement.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Effective anesthesia strategies can help minimize hair loss in patients with telogen effluvium during surgery.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Estrogen alone can lower testosterone in some transfeminine people.

Caffeine is beneficial for skin and hair treatments but needs better delivery methods to penetrate deeper skin layers.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.